Abingdon Health Plc

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:01 2024-04-26 am EDT			5-day change	1st Jan Change
10 ^GBX	0.00%		-4.76%	-9.09%

Mar. 25	Peel Hunt's RetailBook raises GBP2.5 million	AN
Mar. 25	Abingdon Health Completes Design Freeze for STD Self-Tests	MT

Abingdon Health appoints Feather as new interim finance director

October 24, 2023 at 08:28 am EDT

(Alliance News)- Abingdon Health PLC on Tuesday named Andrew Feather as its new interim finance director.

Abingdon Health is a York, England-based lateral flow test contract development and manufacturing company.

Abingdon said Feather has over 25 years experience in financial management. This includes senior roles at Carclo PLC, a West Yorkshire, England-based engineering solutions provider.

Initially, Feather will work with Chief Financial Officer Melanie Ross during a handover period until Ross leaves Abingdon on November 30.

The company announced that Ross was leaving on Wednesday last week.

Shares in Abingdon Health were down 2.5% to 9.99 pence each in London on Tuesday afternoon.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	CARCLO PLC	13 GBX	+75.08%	+73.91%	11.89M
	ABINGDON HEALTH PLC	10 GBX	0.00%	-4.76%	38.36M

Latest news about Abingdon Health Plc

Peel Hunt's RetailBook raises GBP2.5 million	Mar. 25	AN
Abingdon Health Completes Design Freeze for STD Self-Tests	Mar. 25	MT
Abingdon Health to Provide Rapid Self-tests to Boots	Mar. 20	MT
Abingdon Health strikes deal amidst upswing in self testing market	Mar. 20	AN
AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement	Mar. 20	AN
EARNINGS AND TRADING: Smarttech247 and Beeks in deal boosts	Mar. 14	AN
AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps	Mar. 14	AN
London stocks tread water with US data to come	Mar. 14	AN
ABINGDON HEALTH PLC: BOARD EXPECTS THAT H2 REVENUE WILL BE SIGN…	Mar. 14	RE
Abingdon Health plc Provides Earnings Guidance for the Second Half and Full Fiscal Year 2024	Mar. 14	CI
Abingdon Health Plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 14	CI
Abingdon Health shares down despite decent interim results	Jan. 11	AN
Abingdon Health Plc Announces Promotion of Laura Towse as Group Financial Controller	Jan. 11	CI
Abingdon Health plc Announces Resignation of Andrew Feather as Interim Finance Director	Jan. 11	CI
Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023	Jan. 11	CI
Abingdon expects higher half-year revenue	Dec. 15	AN
Stocks edge higher ahead of slew of PMIs	Dec. 15	AN
FTSE 100 Closes Up on Tech Earnings Expectations, Easing Bond Yields	23-10-24	DJ
Abingdon Health appoints Feather as new interim finance director	23-10-24	AN
Abingdon Health Names Interim Finance Director	23-10-24	MT
Abingdon Health Plc Announces Executive Changes	23-10-24	CI
FTSE 100 Closes Down 1.1% on Middle East Tensions	23-10-18	DJ
Abingdon Health finance chief resigns, seeks interim hire	23-10-18	AN
Abingdon Health CFO Plans Exit; Stock Drops	23-10-18	MT
Abingdon Health plc Announces Resignation of Melanie Ross as Director	23-10-18	CI

Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-11-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
ABINGDON HEALTH PLC	-9.09%	38.36M
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances

Abingdon Health Plc

Equities

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Abingdon Health appoints Feather as new interim finance director

Stocks mentioned in the article

Latest news about Abingdon Health Plc

Chart Abingdon Health Plc

Company Profile

Income Statement Evolution

Sector Diagnostic & Testing Substances